The news yesterday from Amgen that panitumumab (Vectibix) failed in Head and Neck cancer got me thinking. Why did it fail where cetuximab (Erbitux) succeeded? They're both monoclonal antibodies to EGFR, so that makes it rather interesting.
TrackBack URL for this entry:
Listed below are links to weblogs that reference Why do some cancer drugs work and others don't?:
The comments to this entry are closed.